BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4318813)

  • 1. Immunological studies with cell cultured aluminium hydroxide gel adsorbed formalin inactivated foot and mouth disease type Asia I monovalent vaccine.
    Negi BS; Kumar S
    Indian Vet J; 1970 Jul; 47(7):555-61. PubMed ID: 4318813
    [No Abstract]   [Full Text] [Related]  

  • 2. Foot-and-mouth disease: a vaccine study.
    McKercher PD; Callis JJ
    Dev Biol Stand; 1976; 35():123-33. PubMed ID: 198278
    [No Abstract]   [Full Text] [Related]  

  • 3. [Foot-and-mouth disease in Ethiopia. Serologic and immunologic study of type A foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1976; 29(2):95-9. PubMed ID: 189363
    [No Abstract]   [Full Text] [Related]  

  • 4. [Several criteria of evaluation of foot-and-mouth disease virus reproduced in cell cultures in suspension].
    Girard HC
    Dev Biol Stand; 1976; 35():91-6. PubMed ID: 71255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foot-and-mouth disease vaccine: influence of the vaccine virus subtype on neutralizing antibody and resistance to disease.
    Graves JH; McKercher PD; Callis JJ
    Am J Vet Res; 1972 Apr; 33(4):765-8. PubMed ID: 4336082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Foot-and-mouth virus component responsible for immunogenesis].
    Salazhov EL; Ivanov VS
    Veterinariia; 1970 Sep; 9():38-40. PubMed ID: 4323895
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study on the immune response of sheep to foot and mouth disease virus vaccine type Asia-1 prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):117-24. PubMed ID: 1314158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of nanogram to milligram quantities of inactivated foot-and-mouth disease virus. II. Comparative response of guinea pigs and steers.
    Morgan DO; McKercher PD; Bachrach HL
    Proc Annu Meet U S Anim Health Assoc; 1968; 72():407-15. PubMed ID: 4308554
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development and use of laboratory procedures in assessing the effectiveness of foot-and-mouth disease vaccines for cattle and swine].
    Thalmann G; Nöckler A; Felfe P; Kreienbrink G
    Arch Exp Veterinarmed; 1987 Nov; 41(6):806-11. PubMed ID: 2831828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Further studies on delayed type foot-and-mouth disease allergy].
    Mayr A; Thein P; Baljer G
    Zentralbl Veterinarmed B; 1970 Nov; 17(9):905-17. PubMed ID: 4326186
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.
    Rweyemamu MM; Pay TW; Parker MJ
    Dev Biol Stand; 1976; 35():205-4. PubMed ID: 198288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
    Rüting E; Seils H; Weyhe D; Benndorf E
    Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic relations between the foot-and-mouth disease virus isolates A5 Westerwald 1951 and A5 Bernbeuren 1984].
    Bengelsdorff HJ
    Berl Munch Tierarztl Wochenschr; 1987 Aug; 100(8):264-8. PubMed ID: 2820373
    [No Abstract]   [Full Text] [Related]  

  • 15. [An optical method for the quantitative detection of antibodies to foot-and-mouth disease virus--initial results].
    Liebermann H; Holl U
    Arch Exp Veterinarmed; 1985 Sep; 39(5):718-22. PubMed ID: 3000308
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to foot-and-mouth disease virus.
    Cowan KM; Wagner GG
    J Dairy Sci; 1971 Sep; 54(9):1329-30. PubMed ID: 4328704
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
    Hyslop NS; Morrow AW
    Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological conditions following natural infection with foot-and-mouth disease virus and after vaccination].
    Eissner G
    Schweiz Arch Tierheilkd; 1967 Jun; 109(6):299-311. PubMed ID: 4300477
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and control of bovine enzootic leukosis. 4. Comparison of antibody formation following inoculation of the Riems concentrated foot-and-mouth disease vaccine in clinicially healthy and in pre-leukotic cattle].
    Seils H; Wittmann W; Weyhe D
    Arch Exp Veterinarmed; 1971 Jun; 25(3):581-6. PubMed ID: 4330772
    [No Abstract]   [Full Text] [Related]  

  • 20. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
    Martel JL
    Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.